Single Blind, Randomized Control Study is designed to evaluate the tolerability of the Celero Systems' modified Health-Dx™ (mHDx) capsule.
Morgantown, West Virginia 26506, United States
Healthy individuals ages 18 - 75 inclusive
Subject is a suitable candidate for study participation in the opinion of the Investigator
Subject has been informed of the nature of the study and has provided written informed consent as approved by the WVU IRB
Subjects with a history of any condition that may impact the GI tract
Subjects who are unable to swallow a 000 sized capsule
Subjects with an implanted medical device that has wireless data communication capability
Subjects planning to undergo an MRI within 30 days after the study
Subjects with a BMI > 40 (severe obesity)
Subjects who are pregnant or are nursing
Any subject deemed to be at risk of a gastrointestinal complication as evaluated by a gastroenterologist prior to study enrollment
Study Contact Info
Contact Listings Owner Form
Tolerability of a Modified Health-Dx 0 reviewsWrite Your Review
There are no reviews yet.